Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel phase transfer catalysis method ensures high-purity Fenofibric Acid with reduced solvent loss and enhanced supply chain reliability for pharmaceutical manufacturing.
Patent CN110590679A enables mild rare earth catalysis for barbituric acid derivatives, offering cost reduction in pharma manufacturing and reliable supply chain continuity.
Patent CN106366031B details a novel chiral resolution route for (S)-Oxiracetam offering high purity and scalable manufacturing capabilities for global pharmaceutical supply chains.
Novel route for palovir intermediate using protected bromoethylamine. High selectivity, mild conditions, and scalable process for API manufacturing.
Patent CN109503542B reveals a green synthesis for Atorvastatin intermediates, eliminating toxic cyanides and reducing EHS risks for reliable API manufacturing.
Novel NHC-Cu catalyzed route for Duloxetine intermediate offers high yield and purity. Cost-effective manufacturing solution for pharmaceutical supply chains.
Patent CN109608401A reveals chitosan-copper catalysis for diarylamines. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing processes.
Novel patent CN104311547A offers efficient thiazole derivative synthesis. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Patent CN116396209B reveals a green photocatalytic route for alkyl perfluoroalkyl ketones. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN104829581A reveals a novel synthesis route for 6-bromo-N-methyl-3,4-dihydro-2H-pyran-3-amine offering improved yield and supply chain stability for global pharmaceutical manufacturers.
Discover the green synthesis of Rosuvastatin Calcium intermediates via novel organometallic routes. Reduce EHS risks and optimize supply chain reliability with our advanced manufacturing capabilities.
Patent CN103224972B reveals high-yield enzymatic synthesis. Offers supply chain stability and cost efficiency for pharmaceutical manufacturers seeking reliable amino acid intermediates.
Novel synthetic route for HCV NS5A inhibitor intermediate offering cost reduction and scalable manufacturing for pharmaceutical supply chains globally.
Patent CN115572317B reveals optimized esterification. Delivers high-purity pharmaceutical intermediates with reduced purification burden for supply chain stability.
Patent CN108047093A details a novel Suzuki coupling route for Sacubitril intermediates. This method ensures high chiral purity and significant cost reduction for scalable pharmaceutical manufacturing.
Novel patent CN120441449A reveals efficient Tobuterol intermediate synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112794849B details a novel, eco-friendly route to 3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, eliminating toxic POCl3 and enhancing supply chain stability.
Patent CN1288133C reveals a 4-step route to Levetiracetam, significantly improving yield and safety over traditional 6-step methods for reliable API supply.
Novel dehydration-epoxidation route for Delta9,11-canrenone achieves >80% yield. Reduces steps vs fermentation. Ideal for eplerenone manufacturing.
Novel green synthesis of risperidone intermediate avoiding POCl3. High yield, scalable process for reliable pharmaceutical intermediate supply.